Colimax 0.6 mg Tablet should be taken orally with water, with or without food, as directed by a healthcare professional.

Atropine Sulfate acts as a competitive antagonist at muscarinic acetylcholine receptors. By blocking these receptors, it inhibits the action of acetylcholine, leading to relaxation of smooth muscles, decreased glandular secretions, and other anticholinergic effects.

• •Hypersensitivity to atropine or any component of the formulation.
• •Glaucoma (especially narrow-angle glaucoma).
• •Prostatic hypertrophy or other obstructive uropathy.
• •Paralytic ileus, pyloric stenosis, or other obstructive gastrointestinal diseases.
• •Myasthenia gravis (except when used to counteract muscarinic effects of anticholinesterases).
• •Tachycardia secondary to cardiac insufficiency or thyrotoxicosis.

Store in a cool, dry place, below 30°C. Protect from light and moisture. Keep out of reach of children.

Symptoms include dry mouth, blurred vision, difficulty swallowing, photophobia, hot and dry skin, fever, rapid pulse, urinary retention, bowel obstruction, and CNS effects (excitement, confusion, delirium, coma). Treatment is supportive, potentially involving physostigmine as an antidote.

Pregnancy Category C. Use only if potential benefit justifies potential risk to the fetus. Atropine is excreted in breast milk; use with caution in breastfeeding mothers due to potential anticholinergic effects on the infant and reduction in milk production.